At Eleusis, we are dedicated to unlocking the full therapeutic potential of psychedelics. Founded in 2013, our company is the leading scientific platform for the clinical evolution of psychedelics into modern medicines. Guided by world-class researchers in the field, as well as care delivery experts, we have a unique Design, Develop, and Delivery approach that combines lab and healthcare capabilities in order to develop treatment options for a wide variety of diseases.
IR Website: https://www.eleusisltd.com/news-views/
Headquarters: London, England
Content provided by Eleusis on 3/2/22.